David Cox, Ph.D.
Retired Biotechnology Executive

Dr. David Cox retired as President & CEO of Radient Technologies Inc. in June 2011. Prior to joining Radient in 2009, Dr. Cox was the CEO of TEC Edmonton for several years. He is an experienced leader in the public and private sectors with direct involvement in biotechnology organizations and has extensive C-Level executive experience in medium-sized pharmaceutical companies as well as small biotech companies, and has substantial experience with capital markets in Canada and the United States. Prior to assuming his position as CEO of TEC Edmonton in 2006, Dr. Cox had spent 12 years as a biotech/pharmaceutical CEO, firstly for Apotex Fermentation Inc in Winnipeg (1994-1997), then SYNSORB Biotech Inc (a TSX and Nasdaq listed company based in Calgary, 1997 – 2002), privately-held KS Avicenna Inc. of Edmonton (2002-2004) and finally Quest PharmaTech Inc, an Edmonton-based company which is publicly traded on the TSX(V) Exchange (2005-2006). Dr. Cox is currently a Director of the Edmonton Southside primary Care Network and past Chair of BioAlberta (the Province’s industry association). He was also a member of the Alberta Premier’s Innovation Council.